23 / 48
23
Symposia
/ Preliminary Scientific Programme
WFSBP 2017
S-23-002
Short-term working memory training for individuals
with psychosis: Cognitive and neurophysiological effects
Christopher Bowie, Canada
S-23-003
Randomised trial of low support cognitive training for
schizophrenia: Cortical and behavioural outcomes
Gary Donohoe, Ireland
S-23-004
SESAME: A brief intervention for memory in schizophre-
nia. Behavioral and imaging data
Martin Lepage, Canada
T4: ANXIETY DISORDERS: BASIC/CLINICAL
S-24
11:15–12:45
Serotonin and anxiety disorders: Recent evidences
from neuroimaging studies
Chair:
Eduard Maron, Estonia
Co-Chair: Tomas Furmark, Sweden
S-24-001
Serotonin system and panic disorder
Eduard Maron, Estonia
S-24-002
Serotonin system and social anxiety disorder
Tomas Furmark, Sweden
S-24-003
Serotonin system and obsessive-compulsive disorder
Oliver Pogarell, Germany
S-24-004
Serotonin regulation of anxiety neuronal network
Andreas Frick, Sweden
T47: STIMULATION METHODS (ECT, TMS, VNS, DBS)
S-25
15:00–16:30
tDCS: From research to clinical practice
Chair:
Emmanuel Poulet, France
Co-Chair: Jerome Brunelin, France
S-25-001
Translational research on tDCS: Data from a German
multisite project
Frank Padberg, Germany
S-25-002
Combining tDCS with neuroimaging
Shirley Fecteau, Canada
S-25-003
Effects of tDCS on biological reactivity to stress and
decision making
Jerome Brunelin, France
S-25-004
TDCS in mood disorders – ready to clinical practice?
Results from recent phase-III randomised, controlled
trials
Andre Brunoni, Brazil
T33: PHARMACOLOGY
S-26
15:00–16:30
Into novel drugs for depression
Chair:
Erich Seifritz, Switzerland
S-26-001
Conceptual strategies of Big Pharma into innovation in
psychiatric therapies: Future leads
Siegfried Kasper, Austria
S-26-002
Personalizing psychiatry treatment
Florian Holsboer, Germany
S-26-003
Psychedelic drugs and clinical markers as innovation
road to psychopharmacotherapy
Franz X. Vollenweider, Switzerland
S-26-004
GHB as a candidate drug for stratified depression
suptypes
Oliver G. Bosch, Switzerland
T43: SCHIZOPHRENIA: BASIC/CLINICAL
S-27
15:00–16:30
Beyond unitary models of psychosis: Confronting
complex etiology and dimensionality
Chair:
Mikhail Pletnikov, USA
Co-Chair: John Waddington, Ireland
S-27-001
Recognising the dimensionality of psychotic illness:
Broadening the phenotype to the affective domain
Catherine Belzung, France
S-27-002
Addressing the translational challenge of etiological
diversity: Complex gene-environment interactions in
risk for psychosis
Mikhail Pletnikov, USA
MON